主页 > 生命科学 >

【drug-news】FDA关于美沙酮的警告发布于11月27日

http://www.fda.gov/cder/drug/infopage/methadone/default.htm

Information for Healthcare Professionals
Methadone Hydrochloride

--------------------------------------------------------------------------------

FDA ALERT [11/2006]: Death, Narcotic Overdose, and Serious Cardiac Arrhythmias

FDA has reviewed reports of death and life-threatening adverse events such as respiratory depression and cardiac arrhythmias in patients receiving methadone. These adverse events are the possible result of unintentional methadone overdoses, drug interactions, and methadone’s cardiac toxicities (QT prolongation and Torsades de Pointes). Physicians prescribing methadone should be familiar with methadone’s toxicities and unique pharmacologic properties. Methadone’s elimination half-life (8-59 hours) is longer than its duration of analgesic action (4-8 hours). Methadone doses for pain should be carefully selected and slowly titrated to analgesic effect even in patients who are opioid-tolerant. Physicians should closely monitor patients when converting them from other opioids and changing the methadone dose, and thoroughly instruct patients how to take methadone. Healthcare professionals should tell patients to take no more methadone than has been prescribed without first talking to their physician. 已认领,如若48小时内未上交译文,请其他站友认领。

阅读本文的人还阅读:

【技术产业】973项目“基

【文摘发布】CRP和白蛋白

【drug-news】FDA批准可直接

1篇关于双生子智力方面

【drug-news】FDA批准Trean

作者:admin@医学,生命科学    2010-09-26 17:11
医学,生命科学网